Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedAug 02, 2026
DataAggregated Company Financials
Companies9
  • 7D1.4%
  • 3M11.5%
  • 1Y-15.0%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 1.4%, with AddLife up 2.6%. However, the industry is down 15% over the past year. Earnings are forecast to grow by 18% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 02 Aug 2026SEK 30.6bSEK 14.8b-SEK 829,177,579.0034.1x-36.9x2.1x
Tue, 30 Jun 2026SEK 31.3bSEK 14.6b-SEK 871,304,353.0036.7x-36x2.1x
Thu, 28 May 2026SEK 29.8bSEK 14.6b-SEK 849,175,077.0037x-35.1x2x
Sat, 25 Apr 2026SEK 29.8bSEK 14.6b-SEK 971,664,077.0034.5x-30.7x2x
Mon, 23 Mar 2026SEK 26.3bSEK 14.6b-SEK 838,374,077.0031.2x-31.4x1.8x
Wed, 18 Feb 2026SEK 26.8bSEK 14.9b-SEK 553,301,427.0032.3x-48.3x1.8x
Fri, 16 Jan 2026SEK 30.0bSEK 14.9b-SEK 744,515,427.0047.4x-40.3x2x
Sun, 14 Dec 2025SEK 32.9bSEK 14.9b-SEK 744,515,427.0054.5x-44.2x2.2x
Tue, 11 Nov 2025SEK 34.7bSEK 14.7b-SEK 748,598,012.0058.1x-46.4x2.4x
Thu, 09 Oct 2025SEK 35.1bSEK 14.7bSEK 61.3m58.4x572.7x2.4x
Sat, 06 Sep 2025SEK 34.9bSEK 14.7bSEK 60.9m56.4x573.1x2.4x
Mon, 04 Aug 2025SEK 35.8bSEK 14.8bSEK 158.0m61.3x226.3x2.4x
Wed, 02 Jul 2025SEK 46.5bSEK 16.6bSEK 416.3m68.5x111.7x2.8x
Fri, 30 May 2025SEK 45.6bSEK 16.6bSEK 404.2m72.3x112.9x2.7x
Sun, 27 Apr 2025SEK 43.1bSEK 16.6bSEK 642.3m44.1x67.1x2.6x
Tue, 25 Mar 2025SEK 36.9bSEK 16.6bSEK 614.3m39x60.1x2.2x
Thu, 20 Feb 2025SEK 44.0bSEK 17.0b-SEK 1,033,505,426.0043.3x-42.6x2.6x
Sat, 18 Jan 2025SEK 39.1bSEK 16.7b-SEK 1,152,911,426.0042.2x-33.9x2.3x
Mon, 16 Dec 2024SEK 44.1bSEK 16.7b-SEK 1,152,911,426.0050.4x-38.3x2.6x
Wed, 13 Nov 2024SEK 44.2bSEK 16.8b-SEK 948,072,426.0050.3x-46.6x2.6x
Fri, 11 Oct 2024SEK 46.5bSEK 16.7b-SEK 988,175,491.0057.2x-47.1x2.8x
Sun, 08 Sep 2024SEK 47.4bSEK 16.7b-SEK 988,176,492.0059.9x-48x2.8x
Tue, 06 Aug 2024SEK 46.3bSEK 16.7b-SEK 1,128,120,510.0058.2x-41x2.8x
Thu, 04 Jul 2024SEK 42.2bSEK 16.3b-SEK 1,188,686,510.0054.2x-35.5x2.6x
Sat, 01 Jun 2024SEK 43.6bSEK 16.3b-SEK 1,188,686,510.0062.9x-36.7x2.7x
Mon, 29 Apr 2024SEK 37.7bSEK 16.2b-SEK 1,246,589,705.0036.2x-30.2x2.3x
Wed, 27 Mar 2024SEK 40.4bSEK 16.0b-SEK 1,122,792,210.0034.6x-36x2.5x
Fri, 23 Feb 2024SEK 39.3bSEK 16.0b-SEK 1,119,170,478.0043x-35.1x2.5x
Sun, 21 Jan 2024SEK 35.8bSEK 15.5b-SEK 1,393,723,683.0042.9x-25.7x2.3x
Tue, 19 Dec 2023SEK 38.2bSEK 15.5b-SEK 1,393,723,683.0045.3x-27.4x2.5x
Thu, 16 Nov 2023SEK 32.3bSEK 15.4b-SEK 1,256,647,710.0036.3x-25.7x2.1x
Sat, 14 Oct 2023SEK 24.0bSEK 15.1b-SEK 1,134,516,711.0033.5x-21.2x1.6x
Mon, 11 Sep 2023SEK 29.2bSEK 15.1b-SEK 1,133,713,072.0038.8x-25.8x1.9x
Wed, 09 Aug 2023SEK 31.8bSEK 15.1b-SEK 213,871,038.0045.7x-148.5x2.1x
Price to Earnings Ratio

-148.5x


Total Market Cap: SEK 31.8bTotal Earnings: -SEK 213,871,038.00Total Revenue: SEK 15.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average 26.4x202420252026
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market1.79%
Healthcare2.74%
Life Sciences1.38%
Clinical Research and Equipment1.38%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ALIF B AddLifeSEK 161.602.6%
+SEK 499.6m		-4.7%PE32.9x
BICO BICO GroupSEK 14.407.6%
+SEK 72.0m		-60.0%PS0.7x
PRO PromimicSEK 10.404.0%
+SEK 7.6m		-42.9%PS3.9x
IDLDX IDL DiagnosticsSEK 0.434.9%
+SEK 4.6m		-22.7%PS1.8x
LEVBIO Level BioSEK 0.271.5%
+SEK 273.6k		-7.6%PS0.5x

Latest News

BICO
SEK 14.40
BICO Group
7D
7.6%
1Y
-60.0%
GENO
SEK 19.58
Genovis AB (publ.)
7D
-2.3%
1Y
-26.5%
Analysis Article • Jul 31

Some May Be Optimistic About Genovis AB (publ.)'s (STO:GENO) Earnings

The market for Genovis AB (publ.)'s ( STO:GENO ) shares didn't move much after it posted weak earnings recently. We...
PEXA B
SEK 0.23
PExA
7D
-1.7%
1Y
-40.4%
MCAP
SEK 548.50
MedCap
7D
-1.4%
1Y
-16.1%
Analysis Article • Jul 24

MedCap AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions

MedCap AB (publ) ( STO:MCAP ) just released its latest second-quarter results and things are looking bullish. It was...
ALIF B
SEK 161.60
AddLife
7D
2.6%
1Y
-4.7%
Analysis Article • Jul 20

Analyst Estimates: Here's What Brokers Think Of AddLife AB (publ) (STO:ALIF B) After Its Second-Quarter Report

AddLife AB (publ) ( STO:ALIF B ) last week reported its latest quarterly results, which makes it a good time for...
MAGLE
SEK 0.51
Magle Chemoswed Holding
7D
-51.0%
1Y
-97.5%
IDLDX
SEK 0.43
IDL Diagnostics
7D
4.9%
1Y
-22.7%
PRO
SEK 10.40
Promimic
7D
4.0%
1Y
-42.9%
LEVBIO
SEK 0.27
Level Bio
7D
1.5%
1Y
-7.6%